Filing Details

Accession Number:
0001633970-15-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-03 17:00:42
Reporting Period:
2015-04-01
Filing Date:
2015-04-03
Accepted Time:
2015-04-03 17:00:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596783 Catalent Inc. CTLT Pharmaceutical Preparations (2834) 208737688
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612357 Aristippos Gennadios C/O Catalent, Inc.
14 Schoolhouse Road
Somerset NJ 08873
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-01 4,690 $12.14 12,606 No 4 M Direct
Common Stock Disposition 2015-04-01 3,072 $30.61 9,534 No 4 F Direct
Common Stock Disposition 2015-04-01 883 $30.61 8,651 No 4 S Direct
Common Stock Acquisiton 2015-04-01 30,310 $10.71 38,961 No 4 M Direct
Common Stock Disposition 2015-04-01 17,227 $30.61 21,734 No 4 F Direct
Common Stock Disposition 2015-04-01 13,083 $30.61 8,651 No 4 S Direct
Common Stock Acquisiton 2015-04-01 11,760 $10.71 20,411 No 4 M Direct
Common Stock Disposition 2015-04-01 6,703 $30.61 13,708 No 4 F Direct
Common Stock Disposition 2015-04-01 5,057 $30.61 8,651 No 4 S Direct
Common Stock Acquisiton 2015-04-01 14,000 $12.14 22,651 No 4 M Direct
Common Stock Disposition 2015-04-01 9,625 $30.61 13,026 No 4 F Direct
Common Stock Disposition 2015-04-01 4,375 $30.61 8,651 No 4 S Direct
Common Stock Acquisiton 2015-04-01 4,704 $12.14 13,355 No 4 M Direct
Common Stock Disposition 2015-04-01 3,234 $30.61 10,121 No 4 F Direct
Common Stock Disposition 2015-04-01 1,470 $30.61 8,651 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2015-04-01 4,690 $0.00 4,690 $14.29
Common Stock Options to purchase common stock Disposition 2015-04-01 30,310 $0.00 30,310 $10.71
Commonstock Options to purchase common stock Disposition 2015-04-01 11,760 $0.00 11,760 $10.71
Common Stock Options to purchase common stock Disposition 2015-04-01 14,000 $0.00 14,000 $12.14
Common Stock Options to purchase common stock Disposition 2015-04-01 4,704 $0.00 4,704 $12.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-05-07 2017-05-07 No 4 M Direct
0 2010-10-23 2019-10-23 No 4 M Direct
0 2010-10-23 2019-10-23 No 4 M Direct
3,500 2012-02-08 2021-02-08 No 4 M Direct
1,176 2012-02-08 2021-02-08 No 4 M Direct
Footnotes
  1. Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options.
  2. These shares were sold in multiple transactions at prices ranging from $30.19 to $30.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. On May 7, 2007, the reporting person was granted an option to purchase 4,690 shares of common stock of the Issuer, which vested and became exercisable in five equal annual installments beginning on May 7, 2008.
  4. On October 23, 2009, the reporting person was granted an option to purchase 30,310 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on October 23, 2010.
  5. On October 23, 2009, the reporting person was granted an option to purchase 11,760 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2010, 2011, 2012, 2013 and 2014. The performance criteria for 2010, 2011, 2012, 2013 and 2014 were met, resulting in vesting of the option as to 11,760 shares.
  6. On February 8, 2011, the reporting person was granted an option to purchase 17,500 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on February 8, 2012.
  7. On February 8, 2011, the reporting person was granted an option to purchase 5,880 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2011, 2012, 2013, 2014 and 2015. The performance criteria for 2011, 2012, 2013 and 2014 were met, resulting in vesting of the option as to 4,704 shares.